Insider Trading Alert - CMN, ASFI And HNRG Traded By Insiders

Yesterday, Dec. 31, 2015, 26 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.73 to $1,310,562.24.

Highlighted Stocks Traded by Insiders:

Cantel Medical (CMN) - FREE Research Report

Krakauer Andrew A, who is Ceo at Cantel Medical, sold 9,438 shares at $62.49 on Dec. 31, 2015. Following this transaction, the Ceo owned 143,341 shares meaning that the stake was reduced by 6.18% with the 9,438-share transaction.

The shares most recently traded at $62.14, down $0.35, or 0.56% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 9,438
  • 12-Week # shares sold: 32,419
  • 24-Week # shares sold: 72,296

The average volume for Cantel Medical has been 137,200 shares per day over the past 30 days. Cantel Medical has a market cap of $2.7 billion and is part of the health care sector and health services industry. Shares are up 46.42% year-to-date as of the close of trading on Wednesday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The company operates through Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis segments. The stock currently has a dividend yield of 0.19%. The company has a P/E ratio of 52.3. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings rates Cantel Medical as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cantel Medical Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Asta Funding (ASFI) - FREE Research Report

Mangrove Partners Master Fund, Ltd., who is 10% Owner at Asta Funding, bought 4,700 shares at $8.00 on Dec. 31, 2015. Following this transaction, the 10% Owner owned 1.5 million shares meaning that the stake was boosted by 0.32% with the 4,700-share transaction.

The shares most recently traded at $7.98, down $0.02, or 0.24% since the insider transaction. Historical insider transactions for Asta Funding go as follows:

  • 4-Week # shares bought: 67,232
  • 12-Week # shares bought: 67,232
  • 12-Week # shares sold: 7,000
  • 24-Week # shares bought: 67,232
  • 24-Week # shares sold: 7,000

The average volume for Asta Funding has been 25,200 shares per day over the past 30 days. Asta Funding has a market cap of $98.4 million and is part of the services sector and diversified services industry. Shares are down 6.86% year-to-date as of the close of trading on Wednesday.

Asta Funding, Inc., together with its subsidiaries, engages in consumer receivable business in the United States. The company operates through four segments: Consumer Receivables, Personal Injury Claims, Structured Settlements, and GAR Disability Advocacy. The company has a P/E ratio of 54.3. Currently, there are no analysts who rate Asta Funding a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASFI - FREE

TheStreet Quant Ratings rates Asta Funding as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. Get the full Asta Funding Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hallador Energy (HNRG) - FREE Research Report

Stabio Victor P, who is Chairman of the Board at Hallador Energy, bought 25,000 shares at $4.71 on Dec. 31, 2015. Following this transaction, the Chairman of the Board owned 289,887 shares meaning that the stake was boosted by 9.44% with the 25,000-share transaction.

The shares most recently traded at $4.56, down $0.15, or 3.29% since the insider transaction. Historical insider transactions for Hallador Energy go as follows:

  • 4-Week # shares bought: 25,000
  • 4-Week # shares sold: 6,720
  • 12-Week # shares bought: 44,875
  • 12-Week # shares sold: 6,720
  • 24-Week # shares bought: 64,875
  • 24-Week # shares sold: 6,720

The average volume for Hallador Energy has been 100,500 shares per day over the past 30 days. Hallador Energy has a market cap of $138.3 million and is part of the basic materials sector and metals & mining industry. Shares are down 56.86% year-to-date as of the close of trading on Wednesday.

Hallador Energy Company, through its subsidiaries, engages in the mining, production, and sale of steam coal for the electric power generation industry in the United States. The stock currently has a dividend yield of 3.36%. The company has a P/E ratio of 5.0. Currently, there are 2 analysts who rate Hallador Energy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HNRG - FREE

TheStreet Quant Ratings rates Hallador Energy as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, a generally disappointing performance in the stock itself and poor profit margins. Get the full Hallador Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

In Trump Era, Managing JPMorgan Is As Unpredictable As a Midnight Tweet

In Trump Era, Managing JPMorgan Is As Unpredictable As a Midnight Tweet

Video: Don't Underestimate China's Strength in a Trade War

Video: Don't Underestimate China's Strength in a Trade War

Master Limited Partnerships: A Badly Missed Investment Opportunity?

Master Limited Partnerships: A Badly Missed Investment Opportunity?

America's Massive Truck Driver Shortage May Triple by 2026: Experts

America's Massive Truck Driver Shortage May Triple by 2026: Experts

Top Analysts Say Gamble On These 3 Ace Stocks

Top Analysts Say Gamble On These 3 Ace Stocks